Physician profile
Savyasachi Thakkar
NPI 1952626335
$216,077.10
in general payments reported to CMS, 2019-2025
15 companies · $102K in 2025
The $102K reported for 2025 was more than what 97% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,270 · 2020: $727 · 2021: $1,189 · 2022: $13K · 2023: $17K · 2024: $79K · 2025: $102K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $123K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $62K · Travel and Lodging: $8,797 · Food and Beverage: $3,836.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $122,654.51 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $62,499.55 |
| Travel and Lodging | $8,796.59 |
| Food and Beverage | $3,836.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $162,313.49 | 2019-2025 | Attune, Velys, Kincise |
| Smith+Nephew, INC. | $28,018.67 | 2020-2025 | Real Intelligence, Journey II, K-15 Pork |
| Depuy Synthes Sales INC. | $11,559.13 | 2019-2025 | Velys, Attune, Actis |
| Depuy Synthes Products, INC. | $9,953.82 | 2024-2025 | Velys, Kincise, Attune |
| Zimmer Biomet Holdings, INC. | $1,296.69 | 2019-2022 | |
| Kci USA, INC. | $947.42 | 2019-2021 | |
| Supreme Orthopedic Systems, LLC | $677.46 | 2019 | |
| Hikma Pharmaceuticals USA | $343.50 | 2024 | Combogesic IV |
| Brainlab, INC. | $213.00 | 2019 | |
| Nuvasive, INC. | $194.84 | 2019 | |
| Baxter Healthcare | $147.68 | 2024 | Perclot, Tisseel |
| Encore Medical, Lp | $143.58 | 2022 | |
| Stryker Corporation | $128.64 | 2021 | |
| Medacta USA, INC. | $91.25 | 2020 | |
| Tactile Systems Technology INC | $47.93 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Savyasachi Thakkar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.